DOGWOOD THERAPEUTICS INC (DWTX) Stock Income Statement
NASDAQ:DWTX - Nasdaq - US92829J2033 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 15.34M | 12.23M | 5.45M | 12.32M | 15.64M | |||
| Research and Development | 5.97M | 3.53M | 1.73M | 8.07M | 10.80M | |||
| Selling, General, and Administrative Expenses | 9.72M | 8.70M | 3.72M | 4.25M | 4.85M | |||
| Operating Income | -15.34M | -12.23M | -5.45M | -12.32M | -15.64M | |||
| Interest Income/Expense | -293.30K | -123.00K | 150.90K | 70.00K | -320.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -21.79M | -12.35M | -5.30M | -12.25M | -15.96M | |||
| Income Tax | N/A | -500.00 | N/A | N/A | N/A | |||
| Net Income | -23.75M | -12.86M | -5.30M | -12.25M | -15.96M | |||
| EBITDA | N/A | -12.22M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -17.93 | -12.52 | -7.05 | -1.11 | -1.92 | |||
| Non GAAP EPS | -13.36 | -10.92 | -7.00 | -32.75 | N/A | |||
| Statistics | ||||||||
All data in USD